Overview
Investment Type
Venture Capital
Funds raised 1
| Date | Fund size | Announcement |
| Sign up to see | Sign up to see | Sign up to see |
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Feb 26, 2026 | ATRO Medical | atromedical.com | $3.51M | Netherlands |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 30, 2026 | Tacalyx Raises €11 Million To Advance Lead Cancer Therapy Toward The Clinic | Tacalyx, a biotech company focused on the discovery and development of cancer therapies directed at Tumor Associated Carbohydrate Antigens, has secured €11 million in a first closing of its seed extension round to advance its lead clinical ... |
| Feb 26, 2026 | ATRO Medical: €3 Million Raised To Advance Artificial Meniscus Toward Pivotal Studies | ATRO Medical, a Netherlands-based clinical-stage orthopedic medical device company, has secured €3 million in a new financing round to advance development of its Artimis Meniscus Prosthesis, an artificial meniscus implant designed for patie... |
| Dec 13, 2025 | Pan Cancer T: €10 Million Funding Raised To Launch In-Human Trial Of TCR-T Cell Therapy For Triple-Negative Breast Cancer | Pan Cancer T, a Rotterdam-based biotech developing next-generation T cell therapies for solid tumours, has raised €10 million to move its lead program, PCT1:CO-STIM, into a first-in-human clinical trial for women with triple-negative breast... |
| May 29, 2025 | Salvia BioElectronics: A New Dawn for Migraine Sufferers | In the world of chronic pain, migraines reign supreme. They are not just headaches; they are life-altering storms that can sweep away productivity, joy, and social connections. For millions, the search for relief is a relentless journey. En... |
| May 27, 2025 | Migraines? This Dutch startup just raised €53 million to transform migraine treatment with its ultra-thin implant | Eindhoven-based Salvia BioElectronics, a clinical-stage medical device company innovating neuromodulation therapy for patients with chronic migraine, today announced the successful completion of their €53 million Series B financing round. T... |
| Nov 10, 2023 | Artica Therapeutics Closes €12M Seed Investment to Develop Covalent Therapeutics for Autoimmune and Inflammatory Disorders. | Leiden, The Netherlands. 2 November, 2023. Artica Therapeutics B.V. (Artica), a biotechnology company unlocking the power of medicines with insurmountable binding characteristics, today announced it has raised €12 million in Seed financing.... |
| Sep 8, 2023 | France-based Gradient Denervation Technologies bag €14M to develop novel pulmonary hypertension therapy | Read this article in: France-based medtech startup Gradient Denervation Technologies announced on Thursday that it had raised €14M in a Series A round of funding. Asabys Partners led the financing effort through its newly established fund, ... |
| Sep 7, 2023 | Gradient Denervation Technologies cierra una serie A de €14m liderada por Sabadell Asabys | 07/09/2023 Nota de prensa GRADIENT DENERVATION TECHNOLOGIES CIERRA UNA SERIE A DE €14M LIDERADA POR SABADELL ASABYS Gradient Denervation Technologies (“Gradient”), una empresa de dispositivos médicos que desarrolla una solución innovador... |
| Nov 18, 2022 | FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant | November 17, 2022 |
Show more
Reviews 0
FAQ about Thuja Capital Management
What funds has Thuja Capital Management raised?
Thuja Capital Management has announced 1 fund on Parsers VC.
How many startups has Thuja Capital Management invested in?
Thuja Capital Management has 2 portfolio companies on Parsers VC, among them ATRO Medical.
What has the press written about Thuja Capital Management?
Parsers VC has collected 12 articles mentioning Thuja Capital Management, among them “Tacalyx Raises €11 Million To Advance Lead Cancer Therapy Toward The Clinic” (Apr 30, 2026) and “ATRO Medical: €3 Million Raised To Advance Artificial Meniscus Toward Pivotal Studies” (Feb 26, 2026).
Is Thuja Capital Management still active?
Yes, Thuja Capital Management is active; its latest activity on Parsers VC dates from Nov 5, 2026.